Last reviewed · How we verify
NCT04738539
Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies
trial testing Contrast Enhanced Voiding Urosonography with Urodynamic Testing in Myelomeningocele in 105 participants. Status unknown.
2 March 2022
Quick facts
| Lead sponsor | University of Virginia |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 105 |
| Start date | 2 March 2021 |
| Primary completion | 2 March 2022 |
| Estimated completion | 2 March 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Contrast Enhanced Voiding Urosonography with Urodynamic Testing — full drug profile →
- Urodynamic Testing
Conditions studied
- Myelomeningocele — all drugs for Myelomeningocele →
- Neurogenic Bladder — all drugs for Neurogenic Bladder →
- Tethered Cord Syndrome — all drugs for Tethered Cord Syndrome →
- Bladder, Neurogenic — all drugs for Bladder, Neurogenic →
Sponsor
University of Virginia
Who can join
Under 18, any sex, with Myelomeningocele or Neurogenic Bladder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will assess the feasibility of replacing fluoroscopy/iodinated contrast with ultrasound/sulfur hexafluoride lipid-type A microspheres during routine urodynamic studies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04738539
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myelomeningocele
Currently open trials in the same condition.
- NCT07048691 — Prenatal and Postnatal Ultrasonographic Evaluation of Myelomeningocele to Predict Post-Surgical Outcomes · active not recruiting
- NCT07465055 — Operating Room Extubation and Postoperative Outcomes in Neonates With Meningomyelocele · active not recruiting
- NCT06042140 — Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair · NA · recruiting
- NCT04243889 — Fetoscopic NEOX Cord 1K® Spina Bifida Repair · NA · active not recruiting
- NCT03410667 — Incontinence and Quality of Life in Children With Spina Bifida · NA · active not recruiting
Other University of Virginia trials
Trials by the same sponsor.
- NCT05880355 — Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI · EARLY_PHASE1 · not yet recruiting
- NCT07405645 — Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy · NA · recruiting
- NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study · Phase 4 · not yet recruiting
- NCT07298941 — Resilience Enhancement Following Sleep Treatment · Phase 2 · recruiting
- NCT07036315 — Meaning in Music-Based Pain Modulation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04738539 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Virginia
- Last refreshed: 28 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04738539.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing